Resource use and disease severity of children hospitalized for COVID-19 versus multisystem inflammatory syndrome in children (MIS-C) in Canada
Daniel Farrar,Charlotte Moore Hepburn,Olivier Drouin,Tala El Tal,Marie-Paule Morin,Roberta Berard,Melanie King,Melanie Laffin Thibodeau,Krista Baerg,Guillaume Beaudoin-Bussières,Camille Beaufils,Terri-Lyn Bennett,Susanne Benseler,Kevin Chan,Claude Cyr,Nagib Dahdah,Elizabeth Donner,Joanne Embree,Catherine Farrell,Andrés Finzi,Sarah Forgie,Ryan Giroux,Kristopher Kang,Bianca Lang,Ronald Laxer,Brian McCrindle,Julia Orkin,Jesse Papenburg,Catherine Pound,Victoria Price,Jean-Phillippe Proulx-Gauthier,Rupeena Purewal,Manish Sadarangani,Marina Salvadori,Roseline Thibeault,Karina Top,Isabelle Viel-Thériault,Elie Haddad,Rosie Scuccimarri,Rae Yeung,Fatima Kakkar,Shaun Morris
DOI: https://doi.org/10.14745/ccdr.v49i04a03
2023-04-01
Abstract:Background: Direct comparisons of paediatric hospitalizations for acute coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C) can inform health system planning. We describe the absolute and relative hospital burden of acute paediatric COVID-19 and MIS-C in Canada. Methods: This national prospective study was conducted via the Canadian Paediatric Surveillance Program from March 2020-May 2021. Children younger than 18 years old and hospitalized for acute COVID-19 or MIS-C were included in the analysis. Outcomes included supplemental oxygen (low-flow oxygen or high-flow nasal cannula), ventilation (non-invasive or conventional mechanical), vasopressors, paediatric intensive care unit (PICU) admission, or death. Adjusted risk differences (aRD) and 95% confidence intervals (CI) were calculated to identify factors associated with each diagnosis. Results: Overall, we identified 330 children hospitalized for acute COVID-19 (including five deaths) and 208 hospitalized for MIS-C (including zero deaths); PICU admission was required for 49.5% of MIS-C hospitalizations versus 18.2% of acute COVID-19 hospitalizations (aRD 20.3; 95% CI, 9.9-30.8). Resource use differed by age, with children younger than one year hospitalized more often for acute COVID-19 (aRD 43.4% versus MIS-C; 95% CI, 37.7-49.1) and more children 5-11 years hospitalized for MIS-C (aRD 38.9% vs. acute COVID-19; 95% CI, 31.0-46.9). Conclusion: While there were more hospitalizations and deaths from acute paediatric COVID-19, MIS-C cases were more severe, requiring more intensive care and vasopressor support. Our findings suggest that both acute COVID-19 and MIS-C should be considered when assessing the overall burden of severe acute respiratory syndrome coronavirus 2 in hospitalized children.